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Background: In recent years, wide implementation of research and clinical next generation
sequencing has led to an astonishing number of novel disease-gene assertions. Recently, loss of
function variants in JARID2 were reported in 16 patients with a clinically distinct
neurodevelopmental phenotype that consisted of neurodevelopmental delay, intellectual disability
(ID), learning disability, autism and behavioral abnormalities. Dysmorphic features were seen in
most patients and included high anterior hairline, deep-set eyes, full lips, broad forehead, bulbous
nasal tip, or depressed nasal bridge. Cleft lip/palate was observed in only 1/16 patients. Most cases
were de novo, with only one inherited case from an affected parent.
Objectives/Goal: The goal of the study was to identify additional patients with JARID2 variants
and further characterize the genotypic and phenotypic spectrum of the disease.
Methods/Design: We searched our internal database for patients with single nucleotide or copy
number variants in JARID2. In one case, we further used long-range PacBio sequencing to aid in the
interpretation of an intragenic duplication in JARID2.
Results: We present a case series of 9 patients with single nucleotide or copy number variants
affecting JARID2. Full gene deletions, intragenic deletions and duplications ranging from 60 kb to
9.4 Mb were detected in 6 patients by clinical microarray. Long range next generation sequencing

of one duplication carrier suggested that it was in tandem. Three patients with loss of function
single nucleotide variants were detected by clinical NGS. Parental testing was not available for most
cases, but family histories of learning disability and behavior abnormalities were noted. In two
cases, the variant was inherited from a mildly affected parent. Most patients had speech delays,
global developmental delays and learning disability (7/9). Behavioral anomalies including autism,
stereotypies, tics, repetitive movements and attention deficit were seen in 4/7 patients.
Heterogeneous neurological abnormalities were observed in 4/7 patients and included ID, gait
disturbances, strabismus, hypotonia, hearing loss, seizures and abnormal MRI findings.
Dysmorphic features were observed in 6/9 patients. Several patients and at-risk relatives showed
cleft lip/palate.
Conclusions: We provide further evidence of a gene-disease association for JARID2 in intellectual
disability. Our results are consistent with previously reported findings and reinforce that the
phenotype may be variable, mild, and inherited from a mildly affected parent. In addition, our data
shows that cleft lip/palate could be more commonly seen than previously reported in patients with
JARID2 variants. We also demonstrate the utility of long-range sequencing in resolving structural
organization of intragenic duplications.

